We are in the era of controlled release formulations, but new emerging technologies are coming, such as fixed dose combinations or those with dual release profile
The ENVI Committee’s adoption of the Compromise Amendments on the SPC manufacturing waiver proposed regulation make genericists happy and originator disappointed.
A sample of Italian workers have been involved in the research "Talents in the Life Science 2018" of Kelly Services, according to which about two thirds (67%) of the respondents work with contractual forms different from the permanent one
Shift the focus from cost to value. An analisys of medical device markets and industry direction of next years, till 2030.
The potential of blockchain technology in the pharmaceutical logistics industry is significant; however, the transition to the effective adoption of these new solutions will require further technological development and the willingness to collaborate on the part of all the actors involved
Next generation biotech could allow 200 years to live in the coming years. Based on Kris Verburgh, medical doctor interested in preventative medicine and aging and author of The Longevity Code "In the near future, we will see a new biotech age unfolding, in which our health, bodies and lifespan will drastically change"
The direct door-to-door selling channel for supplements seems to grow. This data arrived from the Italian Integrators - AIIPA (New Line Market Research data) and AVEDISCO.
A complete range of packaging services for all pharmaceutical forms, with reliability guaranteed by over...
Viela Bio is a new, independent biotech company born from MedImmune - AstraZeneca’s global biologics research...